# DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

> **NCT02711683** · — · COMPLETED · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 92 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** DL-3-n-butylphthalide
- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT02711683
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02711683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02711683, "DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02711683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*